The medical devices sector is typified by frequent change and innovation, in response to problems and issues faced by the healthcare industry. As a result, the sector has seen the emergence of several start-up medtech companies offering disruptive, cutting-edge solutions. Most of these are private companies, where data such as revenue is frequently not disclosed. National estimates for DCN Diagnostics sales in the US from 2017 to 2023, as well as year-on-year growth rates, can be viewed in GlobalData’s micro revenue report. Buy the report here.

Smarter leaders trust GlobalData

Report-cover

Data Insights DCN Diagnostics, United States Revenue

Buy the Report

Data Insights

The gold standard of business intelligence.

Find out more

DCN Diagnostics (DCN) is a contract development and commercialization company. Its product portfolio comprises antibodies, conjugates and general reagents, cellulose nanobeads, lateral flow test strip readers, conjugation kits, material starter kits for lateral flow, and lateral flow materials and cassettes. DCN offers services such as education and training in lateral flow technology, product and technology evaluation services, custom conjugation services, contract lateral flow assay development, contract manufacturing, and consulting services. Its products are used in agricultural and environmental testing, companion diagnostics, consumer diagnostics, food and beverage testing, medical diagnostics, veterinary diagnostics, and nucleic acid lateral flow applications. DCN is headquartered in Carlsbad, California, the US. Key subsidiaries of DCN Diagnostics include BioMed Diagnostics, IVD Vision and PortaScience.

The key metrics of DCN Diagnostics related to marketed and pipeline products, ongoing clinical trials, active jobs and publications from 2023 are shown below:

As DCN Diagnostics is a privately held company, it is not required to disclose its financial information and there is no stock listed on an exchange. GlobalData has access to a proprietary data set containing invoice data from over 2,600 healthcare institutions in the US and is therefore able to use estimations of a company’s revenue and growth to value private companies such as DCN Diagnostics.

For a detailed understanding of the performance of DCN Diagnostics, buy the report here.

Data Insights

From

The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.

GlobalData

GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article. 

GlobalData’s revenue report leverages GlobalData’s SKU tracker, which contains real-world, purchasing data from the US healthcare institutions.